Synthesis of aminoacyl thiaolidones as potential antitumour agents

Biomedicine and Pharmacotherapy

Volumn 60, Issue 3, 2006, Pages 121-126

  Lima Leite, Ana Cristina ^a   Santos, Luciene Maria F ^a   Barbosa, Fábio Fernandes ^a   De Oliveira Cardoso, Marcos V ^a   Moreira, Diogo Rodrigo M ^a   De Souza, Ivone Antonia ^b  

^a CDU   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

4 Thiazolidone; Antitumour agents; Peptidyl derivatives

Indexed keywords

4 THIAZOLIDINONE DERIVATIVE; AMINOACYLTHIAOLIDONE DERIVATIVE; ANTINEOPLASTIC AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREATHING DISORDER; CANCER CHEMOTHERAPY; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; DRUG STRUCTURE; DRUG SYNTHESIS; HYPERACTIVITY; IN VIVO STUDY; INFRARED RADIATION; MALE; MOTOR DYSFUNCTION; MOUSE; MUSCLE TONE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SARCOMA; TREMOR; TUMOR GROWTH;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; FEMALE; MALE; MICE; NEOPLASM TRANSPLANTATION; SARCOMA 180; THIAZOLES;

EID: 33645417997     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2006.01.005     Document Type: Article

References (34)

1. V.L. Almeida, A. Leitão, L.C.B. Reina, C.A. Montanari, C.L. Donnici, and M.T.P. Lopes Câncer e agentes antineoplásicos ciclo celular específicos e ciclo celular não específicos que interagem com o DNA: Uma introdu̧ão Quim. Nova 28 2005 118 129
2. S. Eckhardt Anti-cancer agents Curr. Med. Chem. 2 2002 419 439
3. P.K. Chakravarty, P.L. Carl, M. Weber, and J. Katzenellenbogen Plasmin activated pro-drugs for cancer chemotherapy. Synthesis and biological activity of peptidyl derivatives of doxorubicin J. Med. Chem. 26 1983 633 638
4. D. Haines, R. Fuller, S. Ahmad, D. Vistica, and V. Marquez Selective cytotoxicity of a system L specific amino acid nitrogen mustard J. Med. Chem. 30 1987 542 547
5. A. Trouet, A. Passioukov, K. Derpoorten, A.M. Fernandez, J. Abarca-Quinones, and R. Baurain Extracellularly tumor-activated prodrugs for the selective chemotherapy of cancer: application to doxirubicin and preliminary in vitro and in vivo studies Cancer Res. 61 2001 2843 2846
6. A. Philip, J. Kepler, B. Johnson, and F. Carrol Peptide derivatives of primaquine as potential antimalarial agents J. Chem. Soc. 31 1988 870 874
7. A.C.L. Leite, K.P. da Silva, I.A. de Souza, J.M. De Araújo, and D.J. Brondani Synthesis, antitumour and antimicrobial activities of new peptidyl derivatives containing the 1,3-benzodioxole system. Eur J. Med. Chem. 39 2004 1059 1065
8. W.A. Denny Prodrug strategies in cancer therapy Eur. J. Med. Chem. 36 2001 577 595
9. W. Arap, R. Pasqualini, and E. Ruoslahti Cancer treatment by targets drug delivery to tumor vasculature in a mouse model Science 279 1998 377 380
10. J. Ohmori, M. Shimizu-Sasamata, M. Okada, and S. Sakamoto 8-(1H-Imidazol-1-yl)-7-nitro-4(5H)-imidazo[1,2-a]quinoxalinone and related compounds: synthesis and structure-activity relationships for the AMPA-type non-NMDA receptor J. Med. Chem. 40 1997 2053 2058
11. L. Luca, M. Falorni, G. Giacomelli, and A. Porcheddu New pyrazole containing bicarboxylic alpha-amino acids: mimics of the cis amide bond Tetrahedron Lett. 40 1999 8701 8705
12. L. Luca, M. Falorni, G. Giacomelli, A. Porcheddu, and A.M. Spanedda Synthesis of optically active alpha-amino acids containing pyrazolyl ring as substituent Synthesis (Mass.) 9 2000 1295 1301
13. L.M.F. Santos, A.J. Alves, D.J. Brondani, A.C.C. Freitas, J.G. Lima, and A.C.L. Leite A new series of 1-phenylpyrazole peptidomimetics Heterocyclic Commun 5 1999 407 412
14. K. Hirota, H. Hosono, Y. Kitade, Y. Maki, and C.K. Chu Synthesis and anti-human-immunodeficiency-virus (HIV-1) activity of 3′-deoxy-3′- (triazol-1-il) thymidines and 2′,3′-dideoxy-3′-(triazol-1-yl) uridines, and inhibition of reverse transcriptase by their 5′- triphosphates Chem. Pharm. Bull. (Tokyo) 38 1990 2597 2602
15. T. Boulanger, D.P. Vercauteren, G. Evrard, and F. Durant Trans. Crystal-structure and quantum electronic analyses of pitrazepin, a gamma aminobutyric acid (GABA) receptor antagonist J. Chem. Soc. Perkin. 2 1989 217 219
16. M.J. Drysdale, M.C. Pritchard, and D.C. Horwell Rationally designed dipeptoid analogs of CCK - acid mimics of the potent and selective nonpeptide CCK-B receptor antagonist CI-988 J. Med. Chem. 35 1992 2597 2604
17. J. Cesar, and M. Sollner Use of 3,5-disubstituted 1,2,4-triazoles for the synthesis of peptidomimetics Synth. Commun. 30 2000 41 47
18. Y.O.J. Tong, J. Zabrocki, M.C. Gershengom, G.R. Marshall, and K.D. Moeller Constrained peptidomimetics for TRH: cis-peptide bond analogs Tetrahedron 56 2000 9791 9800
19. T.R. Burke, Z.J. Yao, Y. Gao, J.X. Wu, X. Zhu, and J.H. Luo N-terminal carboxyl and tetrazole-containing amides as adjuvants to Grb2 SH2 domain ligand binding Bioorg. Med. Chem. 9 2001 1439 1442
20. 3 and α-aminoacids from Fmoc protected aspartic acid J. Org. Chem. 68 2003 7316 7321
21. A.C.L. Leite, R.F. Vieira, A.G. Wanderley, P. Afiatpour, E.C.P.A. Ximenes, and R.M. Srivastava Synthesis, anti-inflammatory and antimicrobial activities of new 1,2,4-oxadiazoles peptidomimetics Farmaco 55 2000 719 724
22. J. Clough, S. Chen, E.M. Gordon, C. Hackbarth, S. Larn, and J. Trias Combinatorial modification of natural products: synthesis and in vivo analysis of derivatives of thiazole peptide antibiotic GE2270 A: a-ring modifications Bioorganic & Med. Chem. Lett. 13 2003 3409 3414
23. S.G. Kücukgüzel, E. Oruc, E.S. Rollas, F. Sahin, and A. Özbek Synthesis, characterization and biological activity of novel 4-thiazolidinones, 1,3,4-oxadiazoles and some related compounds Eur. J. Med. Chem. 37 2002 197 203
24. 2-thiazolin-2yl- hydrazones as potential antiprotozoal agents Farmaco 48 1993 1167 1171
25. I.P. Singh, A. Saxena, and K. Shanker Synthesis and anti-inflammatory activity of thiazolidinones and imidazolidinones derivated from thiosemicarbazones Eur. J. Med. Chem. Ther. 20-3 1985 283 287
26. E. Medime, and G. Çapan Synthesis and anticonvulsivant activity of new 4-thiazolidone and 4-thiazoline derivatives Farmaco 49 1994 449 453
27. S. Grasso, N. Micale, A.M. Monforte, P. Monforte, S. Polimeni, and M. Zappalá Synthesis and in vitro antitumour activity evaluation of 1-aryl-1H,3H-thiazolo[3,4-b]quinazolines Eur. J. Med. Chem. 35 2000 1115 1119
28. L. Bukowski, M. Janowiec, Z. Zwolska-Kwiek, and Z. Andrzejczyk Some reactions of 2-cyanomethylimidazo[4,5-b]pyridine with isothiocyanates. Antituberculotic activity of the obtained compounds Pharmazie 53 1998 373 378
29. P.C. Spartan ProUser's Guide 1999 Wavefunction Inc California
30. J. Jones The Chemical Synthesis of Peptides 1994 Oxford University Press New York 229
31. R.I. Geran, A.M. Scumach, B.J. Abbott, N.H. Greenber, and M.M. Macdonal Cancer Chemother Reports 1972 (Part 3, 3 p. 1)
32. C. Lipinski, A.F. Lombardo, B.W. Dominy, and P. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug 46 2001 3 26
33. M.E. Lindgren, M.M. Hallbrink, A.U. Elmquist, and M. Langel Passage of cell-penetrating peptides across a human epithelial cell layer in vitro Biochem. J. 377 2004 69 76
34. Y. Takakura, R.I. Mahato, and M. Hashida Extravation of macromolecules Adv. Drug Del. Rev. 34 1998 93 108